Follow the Satellos Bioscience Inc. share price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares trade on the CA market, under the supervision of SEDI. Market capitalisation: €293.2m. The latest transaction was filed on 20 August 2026 (50 - Grant of options). Among the most active insiders: BERGER, FRANKLIN MILAN. Every trade is openly available.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Satellos Bioscience Inc. Buy (bullish), based on 3 analysts. Average price target: CA$17.67.
28Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
300 shares@ CA$9.020.0010% mcap0.6% of flowCommon SharesTSXSEDI:4752707
Canonical exit: 12 Oct 2026 (T+90)
25 of 30 declarations
About Satellos Bioscience Inc.
Satellos Bioscience Inc. is a biotechnology company focused on developing therapies for muscle diseases. It is listed on the Toronto Stock Exchange (XTSE).